April 17, 2025
FDA Reviews Eylea HD for RVO
April 01, 2025
Second-Generation Anti-VEGF Agents for Neovascular AMD
April 09, 2025
Port Delivery System With Ranibizumab for Diabetic Eye Disease
Latest Headlines
View More
April 24, 2025
Medical Oddities: Back Pain’s Cellular Villains Found?
April 23, 2025
Dry Eye Treatment May Quell Migraine Severity
April 22, 2025
Managing Dry Eye from the First Contact Lens Fitting
April 22, 2025
Improved Outlook for Eye Cancer Diagnostics
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Trending Now
1
Sickle Cell Drug Shows Promise in Stabilizing Vision in Rare Genetic Disease
2
Accuracy of AI-Based Retinal Photographic CVD Risk Assessment
3
Retinal Imaging Captures Alzheimer’s and Dementia Risk
4
FDA Reviews Eylea HD for RVO
5
Are Vision Outcomes Affected by Race in Ranibizumab Treatment for DME?
6
AI Model Shows High Specificity and Sensitivity in DR Screening
Conference Coverage
2025 Global Specialty Lens Symposium
January 01, 0001
Expert-Led Workshops Kick Off GSLS 2025 Educational Program
January 01, 0001
At the Show - Day 1
January 01, 0001
GSLS Course Explores Advanced Myopia Management Strategies
American Academy of Ophthalmology annual meeting
October 01, 2024
Regeneron Leaders Recognized for Innovation at Eyecelerator 2024
October 01, 2024
Hot Topics for the Comprehensive Ophthalmologist
September 01, 2024
An Update on SLT Clinical Trials
American Academy of Optometry annual meeting
November 01, 2024
Life-threatening eye signs and symptoms to keep on your radar
November 01, 2024
Visual field defect testing can be life saving
November 01, 2024
Key indicators of diseases
Clinical Guidelines
View More
April 08, 2025
Occupational (Eye) Hazards
April 01, 2025
A Different Perspective on an Age-Old Disease
April 01, 2025
Compliance Posting Check for the New Year
April 01, 2025
Ocular Surface News - April 9, 2025
Commentary & Perspectives
View More
September 01, 2023
VIEWPOINT FROM THE EDITOR
FDA & Government News
View More
April 17, 2025
FDA Reviews Eylea HD for RVO
April 16, 2025
Biocon, Regeneron Reach Agreement on Eylea Biosimilar
April 16, 2025
FDA Grants RMAT Status to Gene Therapy
April 03, 2025
FDA Reaches Decision on Reproxalap
Business Management
View More
April 01, 2025
